Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GS1-204I12.4 is an uncharacterized long non-coding RNA (lncRNA) gene found in humans. It is expressed in a variety of tissues, including the colonic epithelium and ventricular zone. Its function is not well understood, but as a lncRNA, it may play regulatory roles. Some sources note GS1-204I12.4 expression is repressed in activated lymphocytes, and speculate therapeutic activation may have potential to temper hyperinflammatory states, but there is no direct evidence that it is an actionable therapeutic target. At this time, there are no known interactions with drugs, no established molecular mechanism of action, and no documented disease or biomarker role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GS1-204I12.4.